辅助针改善了呼吸状况,并在严重的COVID-19肺炎后从机械通风中断奶
Jun Matsumoto-Miyazaki1, Hideshi Okada2,3, Tomotaka Miura3
1Department of Cardiology and Respirology, Gifu University Graduate School of Medicine, Gifu, Japan.
Medical acupuncture
|February 21, 2024
概括
针治疗帮助一名严重的COVID-19患者改善了呼吸,并成功摆脱了机械通风 (MV). 这种补充治疗对患有严重肺炎和呼吸衰竭的患者来说是有前途的.
科学领域:
- 关键护理医学 关键护理医学
- 呼吸系统医学 呼吸系统医学
- 综合医学是一个整体的医学.
背景情况:
- 严重的COVID-19肺炎可能导致长时间的机械通风 (MV) 和呼吸衰竭.
- 从MV中断患者可能具有挑战性,特别是在重症监护机构.
- 正在探索辅助疗法,以改善呼吸功能并促进从MV中解放出来.
研究的目的:
- 评估针治疗改善呼吸的疗效.
- 评估针在促进机械通风断奶方面的作用.
- 探索针作为严重的COVID-19肺炎的辅助疗法.
主要方法:
- 一个40多岁的男性患者的病例研究,患有严重的COVID-19肺炎,需要MV.
- 针治疗每周进行4次,从疾病的第49天开始.
- 在整个治疗过程中,对呼吸系统参数和MV断奶状态进行了监测.
主要成果:
- 断奶指数显著改善,包括呼吸速率降低和快速浅呼吸指数.
- 在针治疗后立即观察到增加的氧和.
- 在开始针治疗后8天内成功停止MV治疗.
结论:
- 辅助针治疗改善了呼吸功能,并在严重的COVID-19患者中促进了机械通风和断奶.
- 针可以为从严重肺炎和呼吸衰竭中恢复过来的患者提供好处.
- 需要进一步的大规模研究来证实这些发现.
更多相关视频
02:34Author Spotlight: Efficacy of Auricular Pressure Bean Therapy in Reducing Wheezing Symptoms
Published on: May 10, 2024
943
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
1.4K
相关概念视频
Acute Respiratory Failure-V
139
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
139
Acute Respiratory Failure-III
185
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
185
Acute Respiratory Failure-II
228
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
228
Acute Respiratory Failure-I
208
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
208
Acute Respiratory Failure-IV
157
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
157
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
